# Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore

> **NCT04071782** · NA · COMPLETED · sponsor: **Singapore General Hospital** · enrollment: 25 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **DEVICE:** Drug Coated Balloon

## Key facts

- **NCT ID:** NCT04071782
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-08
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-01-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04071782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04071782, "Investigating the Safety and Efficacy of the Treatment With the Selution Sirolimus Coated Balloon in TASC C and D Tibial Occlusive Disease in Patients With Critical Limb Ischemia From Singapore". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04071782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*